Estimaciones de analistas de Wall Street para Immunovant, Inc. (IMVT): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-09 | $-0.73 | ||
| 2026-08-06 | $-0.75 | $-0.63 | -19.3% |
| 2026-05-20 | $-0.73 | $-0.59 | -23.3% |
| 2026-02-06 | $-0.61 | $-0.72 | +15.3% |
| 2025-11-10 | $-0.73 | $-0.72 | -1.4% |
| 2025-08-11 | $-0.60 | $-0.69 | +13.0% |
| 2025-05-29 | $-0.64 | $-0.71 | +10.3% |
| 2025-02-06 | $-0.76 | $-0.73 | -4.1% |
Ratios de valoración
| Precio / Valor contable | 9.99 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | $21000 | 0 | 0 | 0 | 0 | 0 | $409000 |
| Beneficio Bruto | 0 | 0 | -$21000 | 0 | 0 | 0 | 0 | 0 | -$409000 |
| I+D | $135.3M | $25.7M | $47.9M | $68.6M | $101.8M | $160.3M | $212.9M | $360.9M | $456.7M |
| Generales y Administrativos | $1.5M | $448 | $11.7M | $39.5M | $54.2M | $48.0M | $57.3M | $77.2M | $76.2M |
| Gastos Operativos | $136.7M | $448 | $59.7M | $108.1M | $156.0M | $208.3M | $270.2M | $438.2M | $532.9M |
| Beneficio Operativo | -$136.7M | -$450 | -$59.7M | -$108.1M | -$156.0M | -$208.3M | -$270.2M | -$438.2M | -$532.9M |
| EBITDA | 0 | $9552 | -$65.6M | -$108.1M | -$156.7M | -$198.3M | -$258.5M | -$412.6M | -$505.0M |
| Gastos por Intereses | 0 | 0 | $625000 | 0 | 0 | $12.5M | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$136.7M | -$448 | -$66.3M | -$107.8M | -$156.8M | -$211.0M | -$258.8M | -$412.9M | -$505.4M |
| Impuestos | 0 | 0 | $97000 | -$358000 | -$84000 | $9000 | $567000 | $891000 | $215000 |
| Beneficio Neto | -$136.7M | -$448 | -$66.4M | -$107.4M | -$156.7M | -$211.0M | -$259.3M | -$413.8M | -$505.6M |
| BPA | $-13.68 | $-0.00 | $-1.54 | $-1.22 | $-1.43 | $-1.71 | $-1.88 | $-2.73 | $-2.77 |
| BPA Diluido | $-13.67 | $-0.00 | $-1.54 | $-1.22 | $-1.43 | $-1.71 | $-1.88 | $-2.73 | $-2.77 |
| Acciones en Circulación (Diluidas) | $10.0M | $14.4M | $43.2M | $87.8M | $109.7M | $123.1M | $138.1M | $151.6M | $182.4M |
Precio
| Precio | $36.38 |
| Capitalización | $7.5B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ACAD · AKRO · CRNX · DYN · KYMR · NAMS · PRAX
Explorar sector: Healthcare · Biotechnology
Más secciones de IMVT: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones